Results 201 to 210 of about 46,917 (222)
Some of the next articles are maybe not open access.

[Carbapenemases in Pseudomonas spp].

Enfermedades infecciosas y microbiologia clinica, 2010
Pseudomonas aeruginosa is one of the most relevant nosocomial pathogens, as well as one of the main causes of chronic respiratory infections in patients with underlying diseases such as cystic fibrosis or chronic obstructive pulmonary disease. The high intrinsic antibiotic resistance of this pathogen, together with its extraordinary capacity for ...
Carlos, Juan Nicolau, Antonio, Oliver
openaire   +1 more source

Azetidinimines as carbapenemases inhibitors

2017
The present application relates to novel azetidinimine of formula (I). Wherein R1-R6 are as defined in claim 1. The azetidinimine of the invention are useful as antibiotics and as inhibitors of a carbapenemases. The present invention thus further relates totheir use in antibiotic therapies and their methods of synthesis.
Dodd, Robert   +4 more
openaire   +1 more source

Carbapenemase-Producing Organisms: A Global Scourge

Clinical Infectious Diseases, 2018
Robert A Bonomo, Laurent Poirel
exaly  

Carbapenemases

Pediatric Infectious Disease Journal, 2010
openaire   +2 more sources

Percurso Hospitalar das carbapenemases

2013
The emergence and spread of carbapenem-resistant bacteria has become a serious threat worldwide. Infections caused by these organisms are associated with high rates of mortality and there are few treatment options. Bacteria have several mechanisms that confer resistance to antibiotics, including production of carbapenemase KPC- 3, one β-lactamase with ...
openaire   +1 more source

Occurrence of carbapenemase-producing bacteria in coastal recreational waters

International Journal of Antimicrobial Agents, 2015
Renata Cristina Picão
exaly  

Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates

Journal of Clinical Microbiology, 2018
Pranita Tamma, Patricia J Simner
exaly  

Home - About - Disclaimer - Privacy